CCND1 PROTEIN OVEREXPRESSION

Clinical trials for CCND1 PROTEIN OVEREXPRESSION explained in plain language.

Never miss a new study

Get alerted when new CCND1 PROTEIN OVEREXPRESSION trials appear

Sign up with your email to follow new studies for CCND1 PROTEIN OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat blood cancer

Disease control Ongoing

This study is testing whether two oral medications, venetoclax and acalabrutinib, can help control mantle cell lymphoma that has returned or didn't respond to previous treatments. The trial involves 32 adults who have already tried at least one other therapy. Researchers want to …

Matched conditions: CCND1 PROTEIN OVEREXPRESSION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

CCND1 PROTEIN OVEREXPRESSION

Get alerted when new CCND1 PROTEIN OVEREXPRESSION trials appear

New drug combo tested for Tough-to-Treat blood cancer